HOB Biotech Group Corp.,Ltd (SHA:688656)

SHA:688656 Balance Sheet

Financials in millions CNY. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Sep 30, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	76.06	121.63	163.47	153.8	449.86	58.82
Trading Asset Securities	-	-	-	135.23	5.01	-
Cash & Short-Term Investments	76.06	121.63	163.47	289.03	454.87	58.82
Cash Growth	-27.66%	-25.60%	-43.44%	-36.46%	673.38%	-35.20%
Accounts Receivable	50.79	48.61	41.5	32.38	37.48	29.9
Other Receivables	1.56	2.41	3.94	5.54	3.66	1.39
Receivables	52.34	51.02	45.44	37.92	41.15	31.29
Inventory	109.26	111.22	111.22	87.8	68.2	61.95
Prepaid Expenses	-	-	-	-	-	0.14
Other Current Assets	14.06	8.25	8.09	8.23	5.75	6.46
Total Current Assets	251.72	292.12	328.21	422.98	569.97	158.65
Property, Plant & Equipment	675.91	705.71	578.68	485.27	259.74	119.97
Other Intangible Assets	11.01	10.08	11.86	12.59	12.17	11.29
Long-Term Accounts Receivable	-	-	0.05	0.1	0.62	1.45
Long-Term Deferred Tax Assets	4.07	4.13	2.47	1.78	1.63	0.97
Long-Term Deferred Charges	13.46	12.12	11.58	16.25	10.27	2
Other Long-Term Assets	9.1	8.65	16.4	5.52	9.52	2.08
Total Assets	965.27	1,033	949.26	944.49	863.92	296.41
Accounts Payable	17.15	44.59	23.91	9.37	9.37	6.25
Accrued Expenses	20.14	37.98	34.98	31.06	29.4	22.34
Short-Term Debt	70.01	105.07	50.02	50.01	20.02	20.02
Current Portion of Leases	-	1.1	4.8	5.67	5.51	-
Current Income Taxes Payable	6.91	3.33	4.67	1.53	2.33	-
Current Unearned Revenue	11.24	14.45	14.62	13.33	13.54	9.08
Other Current Liabilities	6.34	3.42	2.74	41.89	6.01	5.53
Total Current Liabilities	133.12	209.94	135.75	152.86	86.17	63.23
Long-Term Debt	-	8	-	-	-	23.98
Long-Term Leases	1.25	1.53	1.03	9.74	5.35	-
Long-Term Unearned Revenue	1.84	1.2	1.74	2.49	2.4	2.81
Long-Term Deferred Tax Liabilities	-	-	-	0.04	0	-
Total Liabilities	136.22	220.67	138.52	165.13	93.92	90.02
Common Stock	63.48	63.06	63.06	63.06	63.06	47.29
Additional Paid-In Capital	571.96	562.98	553.46	550.62	549.35	68.65
Retained Earnings	213.33	205.82	193.92	165.51	157.49	90.32
Treasury Stock	-20.01	-20.01	-	-	-	-
Comprehensive Income & Other	0.29	0.29	0.29	0.18	0.1	0.13
Shareholders' Equity	829.05	812.14	810.73	779.36	770	206.39
Total Liabilities & Equity	965.27	1,033	949.26	944.49	863.92	296.41
Total Debt	72.6	115.69	55.86	65.43	30.88	44
Net Cash (Debt)	3.46	5.93	107.61	223.6	423.99	14.81
Net Cash Growth	-	-94.49%	-51.88%	-47.26%	2762.22%	-63.59%
Net Cash Per Share	0.05	0.09	1.68	3.54	6.89	0.31
Filing Date Shares Outstanding	58.97	62.26	62.72	63.06	63.06	47.29
Total Common Shares Outstanding	58.97	62.26	63.06	63.06	63.06	47.29
Working Capital	118.6	82.18	192.46	270.12	483.8	95.43
Book Value Per Share	14.06	13.04	12.86	12.36	12.21	4.36
Tangible Book Value	818.04	802.06	798.87	766.77	757.83	195.1
Tangible Book Value Per Share	13.87	12.88	12.67	12.16	12.02	4.13
Buildings	-	1.25	20.53	20.53	17.34	17.34
Machinery	-	848.29	249.06	214.57	167.93	126.92
Construction In Progress	-	4.83	422.97	325.75	128.88	24.86

Source: S&P Global Market Intelligence. Standard template. Financial Sources.